CLEVELAND—(BUSINESS WIRE)—Medical device and technology company Lazurite™ today announced that its ArthroFree™ Wireless Camera System for minimally invasive surgery will be available for viewing and hands-on demonstration at the American College of Surgeons’ Clinical Congress 2022, October 16–20 in San Diego at Booth 1111.
The ArthroFree System is the first wireless surgical camera system to receive 510(k) clearance from the Food and Drug Administration for arthroscopy and general endoscopy. Laith M. Jazrawi, MD performed the first-in-man surgery using the ArthroFree System in mid-September at NYU Langone Orthopedic Center.
“We look forward to bringing the ArthroFree Wireless Camera System to the American College of Surgeons Clinical Congress for the first time,” Lazurite CEO and cofounder Eugene Malinskiy said. “By eliminating conventional camera cables that tether the surgeon to the surgical tower, the ArthroFree System is expected to increase OR efficiency and lower customer costs. Additionally, with its solid-state, low-heat, high-efficiency light technology, the system promises to eliminate camera-related patient burns and OR fires. ArthroFree is a modular system designed to be drop-in compatible with existing patient data consoles, surgical displays, and endoscopes found in minimally invasive operating rooms.”
Lazurite is a medical device and technology company. Its ArthroFree™ System—the wireless camera for arthroscopy and general endoscopy—is designed for surgeons seeking surgical tools for greater agility in the OR. ArthroFree is drop-in compatible with current OR technologies and it eliminates the camera cables that hinder surgeons and can cause staff trips and falls. The system’s solid state, low heat, high efficiency Meridiem™ light technology promises to eliminate camera related patient burn and OR fires. With the commercialization of the ArthroFree System, Lazurite launched the wireless era of surgical visualization. Lazurite’s intellectual property portfolio also includes the Meridiem light technology, wireless communication technology, and products in development. The pre-revenue company is located in Cleveland, OH (est. 2015), and to date has raised ~$25M from institutional investors, family offices, and more than 70 physician champions. The mission: solve impossible problems to improve people’s lives. The 10-year vision: better outcomes for 10 million patients—and thousands of clinicians, too. For more information, see: https://lazurite.co.
Visit lazurite.co/media for videos, logos, images, fact sheets, bios and more.
This press release includes “forward-looking statements.” Forward-looking statements can be identified by words such as: “anticipate,” “intend,” “plan,” “believe,” “project,” “estimate,” “expect,” “may,” “should,” “will,” “designed,” “milestone,” and similar references to future periods. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations, and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy, and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks, and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Any forward-looking statement made by us in this press release is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.
Lazurite™ is a trademark of Lazurite LLC.